CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market buy Director bought 50,000 shares at $4.89 ($244,500)
- 4 Open-market buy Director bought 100,000 shares at $4.89 ($489,000)
- 4 Open-market buy Director bought 1,431,493 shares at $4.89 ($7,000,001)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Open-market buy President and CEO bought 5,000 shares at $4.45 ($22,250)
- 10-K Report Annual Report
- 4 Grant or award President and CEO acquired 11,549 shares (grant or award)
- 4 Open-market sale SVP, Chief Medical Officer sold 2,617 shares at $5.32 ($13,928)
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 5,284 shares at $5.25 ($27,762)
- 4 Open-market sale VP, Fin. and Admin., CFO sold 2,537 shares at $5.51 ($13,966)
- 4 Open-market sale Sr. VP, Drug Development sold 18,270 shares at $5.23 ($95,552)
- 8-K Event Other events
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Other events
- 4 Grant or award Sr. VP, Business & Comm. Dvp. acquired 25,000 shares (grant or award)
Page 50 of 62 · 1,224 filings